|
gptkb:Lokelma
|
hyperkalemia
|
|
gptkb:trastuzumab_(antibody)
|
HER2-positive cancers
|
|
gptkb:SDG_12
|
12.3.1
|
|
gptkb:2001_Index_of_Economic_Freedom
|
monetary freedom
|
|
gptkb:Remicade
|
moderate to severe rheumatoid arthritis
|
|
gptkb:evolocumab
|
cardiovascular risk reduction
|
|
gptkb:SI19
|
epilepsy
|
|
gptkb:Gavreto
|
gptkb:RET_fusion-positive_cancers
|
|
gptkb:Ivacaftor
|
gptkb:G551D_mutation_in_CFTR
|
|
gptkb:Polivy
|
relapsed or refractory diffuse large B-cell lymphoma
|
|
gptkb:piperacillin-tazobactam
|
gynecological infections
|
|
gptkb:Lonsurf
|
patients previously treated with anti-EGFR therapy (if RAS wild-type)
|
|
gptkb:Ery-Tab
|
pertussis
|
|
gptkb:SRO_(Standing_Room_Only)
|
tickets sold for standing area only
|
|
gptkb:Tantrums
|
gptkb:Attention_deficit_hyperactivity_disorder
|
|
gptkb:anti-HBe_antibody
|
seroconversion from HBeAg to anti-HBe
|
|
gptkb:CHEMBL1428
|
angina pectoris
|
|
gptkb:Evkeeza
|
reduction of LDL cholesterol
|
|
gptkb:Prevnar_13
|
prevention of pneumococcal disease
|
|
gptkb:Abnormal_Lung_Sounds
|
Pulmonary Fibrosis
|